1. Home
  2. LGVN vs VS Comparison

LGVN vs VS Comparison

Compare LGVN & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • VS
  • Stock Information
  • Founded
  • LGVN 2014
  • VS 2013
  • Country
  • LGVN United States
  • VS United States
  • Employees
  • LGVN 25
  • VS N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • VS EDP Services
  • Sector
  • LGVN Health Care
  • VS Technology
  • Exchange
  • LGVN Nasdaq
  • VS Nasdaq
  • Market Cap
  • LGVN 11.5M
  • VS 11.0M
  • IPO Year
  • LGVN 2021
  • VS N/A
  • Fundamental
  • Price
  • LGVN $0.81
  • VS $2.32
  • Analyst Decision
  • LGVN Strong Buy
  • VS Hold
  • Analyst Count
  • LGVN 3
  • VS 1
  • Target Price
  • LGVN $6.33
  • VS $2.00
  • AVG Volume (30 Days)
  • LGVN 1.9M
  • VS 26.4K
  • Earning Date
  • LGVN 08-13-2025
  • VS 08-14-2025
  • Dividend Yield
  • LGVN N/A
  • VS N/A
  • EPS Growth
  • LGVN N/A
  • VS N/A
  • EPS
  • LGVN N/A
  • VS N/A
  • Revenue
  • LGVN $2,073,000.00
  • VS $2,183,196.00
  • Revenue This Year
  • LGVN N/A
  • VS $3,459.21
  • Revenue Next Year
  • LGVN $51.48
  • VS N/A
  • P/E Ratio
  • LGVN N/A
  • VS N/A
  • Revenue Growth
  • LGVN 68.67
  • VS 1873.85
  • 52 Week Low
  • LGVN $0.63
  • VS $1.00
  • 52 Week High
  • LGVN $2.86
  • VS $9.59
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 30.47
  • VS 47.88
  • Support Level
  • LGVN $0.63
  • VS $2.22
  • Resistance Level
  • LGVN $0.94
  • VS $2.72
  • Average True Range (ATR)
  • LGVN 0.16
  • VS 0.16
  • MACD
  • LGVN -0.09
  • VS -0.00
  • Stochastic Oscillator
  • LGVN 11.37
  • VS 42.25

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Share on Social Networks: